Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DYNDYN
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DYNE THERAPEUTICS INC

Yes. Goldman Sachs holds 2,157,195 shares of DYN (Dyne Therapeutics), worth $47.9M, as of its Q2 2026 13F filing. It increased the position by 434,079 shares (+25.2%) from Q1 2026. Goldman Sachs has held DYN in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$47.9M

Current Shares

2.2M

Total Value Change

+$47.5M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+25.2%
$47.9M0.0%$22.21
36
2026-Q1
Decreased
1.7M
-24.5%
$31.2M0.0%$14.60
0
2025-Q4
Increased
2.3M
+20.1%
$44.7M0.0%$19.20
35
2025-Q3
Increased
1.9M
+41.8%
$24M0.0%$12.37
38
2025-Q2
Increased
1.3M
+34.7%
$12.8M0.0%$9.57
36
2025-Q1
Increased
994,886
+58.2%
$10.4M0.0%$11.45
40
2024-Q4
Decreased
628,703
-6.2%
$14.8M0.0%$23.56
0
2024-Q3
Decreased
670,484
-68.0%
$24.1M0.0%$35.92
0
2024-Q2
Increased
2.1M
+26.2%
$74M0.0%$35.29
37
2024-Q1
Increased
1.7M
+43.1%
$47.2M0.0%$28.39
39
2023-Q4
Decreased
1.2M
-23.0%
$15.4M0.0%$13.30
0
2023-Q3
Decreased
1.5M
-24.9%
$13.5M0.0%$8.96
0
2023-Q2
Increased
2M
+34.5%
$22.6M0.0%$11.25
37
2023-Q1
Increased
1.5M
+78.8%
$17.2M0.0%$11.52
43
2022-Q4
Increased
836,017
+110.3%
$9.7M0.0%$11.59
45
2022-Q3
Increased
397,570
+502.0%
$5M0.0%$12.70
43
2022-Q2
First report
66,043
-
$454,0000.0%$6.87
0

Other major holders of DYN: FMR LLC, BlackRock, Inc., Janus Henderson Group Ltd., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used